Safety First Trust Principal-Protected Certificates Linked TO A U.S.-Europe-Japan Basket (AMEX:ATA)
Historical Stock Chart
From Mar 2020 to Mar 2025

Apogee Technology, Inc. (AMEX:ATA), an emerging micro-systems and
nanotechnology company that designs, develops and commercializes medical
devices and sensor products, will hold a conference call to discuss its
First Quarter 2007 results and recent developments on Wednesday, May 16,
2007, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time).
This call is being webcast by CCBN and can be accessed at Apogee's web
site at www.apogeemems.com.
The call can also be accessed via teleconference using the following
dial-in and passcode numbers:
Dial In # 866-831-6247
International Dial In # 617-213-8856
Participant Passcode 17384781
The webcast is also being distributed over CCBN's Investor Distribution
Network to both institutional and individual investors. Individual
investors can listen to the call through CCBN's individual investor
center at www.fulldisclosure.com
or by visiting any of the investor sites in CCBN's Individual Investor
Network. Institutional investors can access the call via CCBN's
password-protected event management site, StreetEvents (www.streetevents.com).
About Apogee Technology, Inc.
Apogee Technology designs, develops and commercializes proprietary
medical device and sensor products using its MEMS and nanotechnology for
the medical, automotive, industrial and consumer markets. The Company is
developing its PyraDerm(TM) solution for enhanced intradermal drug
delivery and has introduced a family of pressure sensors under the
Sensilica(R) brand. Apogee's goal is to provide value-added and
cost-saving solutions for our customers and, in so doing, become a
global leader in the sensor and medical device fields. For more
information please visit our web site at: http://www.apogeemems.com.
PyraDerm(TM) and Sensilica(R) are trademarks of Apogee Technology, Inc.
All other product names noted herein may be trademarks of their
respective holders. Certain statements made herein that use the words
"anticipate," "hope," "estimate," "project," "will," "intend," "plan,"
"expect," "believe" and similar expressions are intended to identify
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements involve
known and unknown risks and uncertainties, which could cause the actual
results, performance or achievements of the Company to be materially
different from those that may be expressed or implied. Please refer to
the company's risk factors as set forth in the Company's filings with
the Securities and Exchange Commission, including its reports on Forms
10-KSB and 10-QSB.